↓ Skip to main content

Dove Medical Press

Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability

Overview of attention for article published in Therapeutics and Clinical Risk Management, May 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#26 of 1,323)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
8 news outlets
blogs
1 blog

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
64 Mendeley
Title
Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability
Published in
Therapeutics and Clinical Risk Management, May 2013
DOI 10.2147/tcrm.s30071
Pubmed ID
Authors

CY Pan, XL Wang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Unknown 63 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 20%
Student > Postgraduate 8 13%
Student > Bachelor 7 11%
Other 6 9%
Researcher 5 8%
Other 10 16%
Unknown 15 23%
Readers by discipline Count As %
Medicine and Dentistry 24 38%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Nursing and Health Professions 5 8%
Agricultural and Biological Sciences 4 6%
Biochemistry, Genetics and Molecular Biology 2 3%
Other 5 8%
Unknown 17 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 68. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2020.
All research outputs
#631,385
of 25,371,288 outputs
Outputs from Therapeutics and Clinical Risk Management
#26
of 1,323 outputs
Outputs of similar age
#4,356
of 204,326 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 11 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,326 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.